Cargando…
ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential
On 11 March 2020, the World Health Organization (WHO) classified the Coronavirus Disease 2019 (COVID-19) as a global pandemic, which tested healthcare systems, administrations, and treatment ingenuity across the world. COVID-19 is caused by the novel beta coronavirus Severe Acute Respiratory Syndrom...
Autores principales: | Deb, Subrata, Reeves, Anthony Allen, Hopefl, Robert, Bejusca, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308800/ https://www.ncbi.nlm.nih.gov/pubmed/34358081 http://dx.doi.org/10.3390/ph14070655 |
Ejemplares similares
-
Simulation of Physicochemical and Pharmacokinetic Properties of Vitamin D(3) and Its Natural Derivatives
por: Deb, Subrata, et al.
Publicado: (2020) -
The evaluation of ADME and pharmacokinetic properties of decoquinate derivatives for the treatment of malaria
por: Watson, Daniel J., et al.
Publicado: (2022) -
ADME Considerations and Bioanalytical Strategies for Pharmacokinetic Assessments of Antibody-Drug Conjugates
por: Mou, Si, et al.
Publicado: (2018) -
Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development
por: Tibbitts, Jay, et al.
Publicado: (2015) -
ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs
por: Chaira, Tridib, et al.
Publicado: (2023)